Successful hematopoietic stem-cell transplantation in a patient with chronic granulomatous disease and McLeod phenotype sensitized to Kx and K antigens

Bone Marrow Transplantation

Volumn 45, Issue 1, 2010, Pages 209-211

  Honig M ^a   Flegel, W A ^a,c   Schwarz, K ^a   Freihorst, J F ^b,d   Baumann, U ^b   Seltsam, A ^b,e   Debatin, K M ^a   Schulz, A S ^a   Friedrich, W ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d Ostalb Klinikum   (Germany)

^e DRK Blutspendedienst Springe   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; K ANTIGEN; KX ANTIGEN; LACTATE DEHYDROGENASE; LYMPHOCYTE ANTIGEN; RITUXIMAB; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ANTIGEN EXPRESSION; CASE REPORT; CD34 SELECTION; CHILD; CHROMOSOME DELETION X; CHRONIC GRANULOMATOUS DISEASE; CHRONIC LUNG DISEASE; ERYTHROCYTE TRANSFUSION; GRANULOCYTE TRANSFUSION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOGLOBINURIA; HEMOLYSIS; HISTOCOMPATIBILITY; HLA MATCHING; HUMAN; HUMAN CELL; LACTATE DEHYDROGENASE BLOOD LEVEL; LETTER; LUNG ASPERGILLOSIS; LUNG SURGERY; LYMPHADENOPATHY; MALE; PERIPHERAL BLOOD STEM CELL; PHENOTYPE; PNEUMONIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCHOOL CHILD; SENSITIZATION; STEM CELL MOBILIZATION; WHOLE BODY RADIATION;

ADOLESCENT; ANTIGENS, BACTERIAL; ANTIGENS, SURFACE; BASE SEQUENCE; CHILD; CHILD, PRESCHOOL; GENE DELETION; GRANULOMATOUS DISEASE, CHRONIC; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; MALE;

EID: 75149126079     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2009.115     Document Type: Letter

References (11)

1. Roos D, Kuijpers T, Curnutte J. Chronic granulomatous disease. In: Ochs H, Smith E, Puck J (eds). Primary Immunodeficiency Diseases, 2nd edn. Oxford University Press: Oxford, New York, 2007 525-549.
2. Lee S, Russo D, Redman CM. The Kell blood group system: Kell and XK membrane proteins. Semin Hematol 2000; 37: 113-121. (Pubitemid 30211150)
3. Brzica Jr SM, Pineda AA, Taswell HF, Rhodes KH. Chronic granulomatous disease and the McLeod phenotype. Successful treatment of infection with granulocyte transfusions resulting in subsequent hemolytic transfusion reaction. Mayo Clin Proc 1977; 52: 153-156.
4. van der Hart M, Szaloky A, van Loghem JJ. A 'new' antibody associated with the Kell blood group system. Vox Sang 1968; 15: 456-458.
5. Bansal I, Jeon HR, Hui SR, Calhoun BW, Manning DW, Kelly TJ et al. Transfusion support for a patient with McLeod phenotype without chronic granulomatous disease and with antibodies to Kx and Km. Vox Sang 2008; 94: 216-220.
6. Pu JJ, Redman CM, Visser JW, Lee S. Onset of expression of the components of the Kell blood group complex. Transfusion 2005; 45: 969-974.
7. Wagner T, Berer A, Lanzer G, Geissler K. Kell is not restricted to the erythropoietic lineage but is also expressed on myeloid progenitor cells. Br J Haematol 2000; 110: 409-411.
8. Suzuki N, Hatakeyama N, Yamamoto M, Mizue N, Kuroiwa Y, Yoda M et al. Treatment of McLeod phenotype chronic granulomatous disease with reduced-intensity conditioning and unrelated-donor umbilical cord blood transplantation. Int J Hematol 2007; 85: 70-72.
9. Kordes U, Binder TMC, Eiermann TH, Hassenpflug- Diederich B, Hassan MA, Beutel K et al. Successful donorlymphocyte infusion for extreme immune-hemolysis following unrelated BMT in a patient with X-linked chronic granulomatous disease and McLeod phenotype. Bone Marrow Transplant 2008; 42: 219-220.
10. Franchini M, Gandini G, Aprili G. Non-ABO red blood cell alloantibodies following allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2004; 33: 1169.
11. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM et al. The human genome browser at UCSC. Genome Res 2002; 12: 996-1006.